Login

Balance Sheets

In millions of USD, except per-share amounts
Q3 FY2023
As of Sep 30, 2023
Q2 FY2023
As of Jul 20, 2023
Q1 FY2023
As of Mar 31, 2023
Q4 FY2022
As of Dec 31, 2022
Q3 FY2022
As of Sep 30, 2022
Q2 FY2022
As of Jun 30, 2022
Q1 FY2022
As of Mar 31, 2022
ASSETS
Current Assets:
Cash
Prepaid expenses
Prepaid Consulting Services
Other current assets
Total Current Assets
Other assets
Deferred offering costs
Investments held in the Trust Account
Total Assets
LIABILITIES, COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION AND STOCKHOLDER'S DEFICIT
Liabilities
Current Liabilities:
Accounts payable and accrued expenses
Accrued offering costs
Advances from related party
Franchise tax payable
Excise tax payable
Income tax payable
Note payable—Sponsor
Total Current Liabilities
Other long-term liabilities
Deferred underwriting commission
Total Liabilities
Class A common stock subject to possible redemption; 4,644,647 and 23,000,000 shares outstanding as of September 30, 2023 and December 31, 2022, respectively (at redemption price)
Stockholders' deficit:
Preferred shares, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding
Common Stock, Value, Issued
Common Class A
Common Class B
Additional paid-in capital
Accumulated deficit
Total Stockholders' Deficit
Total Liabilities, Common Stock subject to Possible Redemption and Stockholders' Deficit

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support